Share Name Share Symbol Market Type Share ISIN Share Description
Deltex Medical Group Plc LSE:DEMG London Ordinary Share GB0059337583 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.05 -3.17% 1.53 69,495 12:50:16
Bid Price Offer Price High Price Low Price Open Price
1.50 1.55 1.58 1.53 1.58
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 4.96 -1.34 -0.30 8.0
Last Trade Time Trade Type Trade Size Trade Price Currency
13:39:01 O 37,495 1.53 GBX

Deltex Medical (DEMG) Latest News

More Deltex Medical News
Deltex Medical Takeover Rumours

Deltex Medical (DEMG) Share Charts

1 Year Deltex Medical Chart

1 Year Deltex Medical Chart

1 Month Deltex Medical Chart

1 Month Deltex Medical Chart

Intraday Deltex Medical Chart

Intraday Deltex Medical Chart

Deltex Medical (DEMG) Discussions and Chat

Deltex Medical Forums and Chat

Date Time Title Posts
26/6/201921:49Deltex Medical - a British success story!10,069
07/2/201910:52Deltex Medical - winner or doomed to fail? 183
19/6/201812:15Deltex Medical interview with new CEO1
06/6/201821:52Interview with Deltex Medical Group 1
14/7/201411:16Deltex Medical-Optimal Growth Stock10,005

Add a New Thread

Deltex Medical (DEMG) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2019-06-26 12:39:021.5337,495573.67O
2019-06-26 08:51:431.5332,000489.60O
View all Deltex Medical trades in real-time

Deltex Medical (DEMG) Top Chat Posts

Deltex Medical Daily Update: Deltex Medical Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker DEMG. The last closing price for Deltex Medical was 1.58p.
Deltex Medical Group Plc has a 4 week average price of 1.50p and a 12 week average price of 1.15p.
The 1 year high share price is 2p while the 1 year low share price is currently 0.70p.
There are currently 512,268,109 shares in issue and the average daily traded volume is 1,109,002 shares. The market capitalisation of Deltex Medical Group Plc is £7,812,088.66.
bigt20: Nobbygnome 14 May '19 - 09:52 - 9908 of 9926 From my discussions with Andy, there is no doubt in my mind that the company is sustainably cash flow positive. ---> May be the foundation for a better future and a upward moving share price!
gnnmartin: Either that, or the share price is holding up very well to the selling. Buywell has a point, but not one worth making quite so many times. Personally I am encouraged by the move to profitability in the last two quarters.
schloo: MrC Deltex share price unlikely to correct until after results unless there is some unexpected news, so it is frustrating that they are taking so much longer than they used to to get them out, but the recent decline has been on tiny volumes. And the delay could be because of having to wait a bit after the Chairman spent £100,000 buying more shares We should expect some good news with the results in April. Cash positive trading is the big one, followed by growth in the US and key distributor markets. We should also be looking for milestones passed on new product developments Agree that LID should not be worth more than DEMG and that it will need more cash, but LID is actually looking quite cheap itself and that bodes well for a strong increase in DEMG Onwards to thruppence and beyond! Schloo
mrc2u: ArfSorry for any confusion. I have neither a yacht nor a daughter.Yachts always seem to have girl not boy names, I know not why.It is all very confusing and difficult. Perhaps it will be for the best to settle for an 18p share price and forget the yacht.MrC
arf dysg: Smithie or no Smithie, I have a memory of buying the shares and also an acute awareness of the current share price. I can mentally draw a graph of price versus time, so I'm not looking for a third party to help me to work out if the slope of the graph is positive or negative.
arf dysg: I like the way the six-month share-price graph ignores the dizzy heights of previous times, so it looks as if the recent behaviour of the share price is an ABSOLUTELY MASSIVE INCREASE. The trend is clearly to INFINITY and BEYOND!!!!!!!!
arf dysg: We're up! We're up! The share price is higher than it has been for weeks! We're saved, saved, SAVED I tell you!
yump: I think he might have bought because on any sign of profit in the next 5 years, this share price will be peanuts. Depends what your average price is of course. For the placees its very low. Directors have longer timescales than pi's. If you thought you'd got a chance of profit in say 3 years, you'd just stick a few figures in and then see what 1.5p looked like as a share price. We can do that as well, although its not much consolation if your average is 10p (I have no idea what mine is as stopped taking any notice a while ago!)
yump: If they are actually moving towards break even, they'll find it fairly easy to raise a few hundred thousand. With the share price though, I think what will happen is that the vulture traders who buy shares where the share price has bombed, will do their best to get as many pi's as possible to sell out, by talking about liquidation, cash flow etc. etc., driving the share price artifically low. Then they'll buy in for a quick 50-100% when a few test buys move the price up. When it moves up suddenly, there'll be a bit of ramping and it will look credible, so some gullible pi's will also buy. Allowing the traders to sell out for a nice profit. Also, as always, it will attract anyone who has now been 'proved right', despite originally having dodgy arguments, although they would never have appeared ever again if they had been proved wrong. That would require too much integrity.
doglover2003: -- > Feb 30th DEMG management would certainly defend the company very determinedly and would not be recommending any offer to shareholders unless of several multiples of turnover and payable 100 per cent in cash. Therefore, I think you would find that DEMG management would make the Optimise Trial a very important issue for LIDCO shareholders. Any offer by LIDCO would probably produce a re-rating of DEMG and a hammering for LIDCO share price which would make the whole takeover unworkable. Even today LIDCO failed to produce evidence in support of their technology without mentioning DEMG in the same breadth as part of the trial. As for the DEMG share price, the substantial fall in the share price took place on very modest volumes. Conversely, it would not take mega volume to move the price in the opposite direction. DL
Deltex Medical share price data is direct from the London Stock Exchange
Your Recent History
Deltex Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190626 23:57:05